The pharmacist’s guide to navigating flu vaccine options
By Dr. Monica Trivedi at Marshall B. Ketchum University
Pharmacy
Inmar Intelligence reaches agreement with the DEA
The agreement results from 18 months of collaboration between Inmar and DEA officials to interpret regulations on reverse distribution of controlled substances.
APCI applauds Governor, Legislature for passage of SB 252
SB 252 was crafted to bring long-overdue transparency to prescription drug pricing, ensure fair reimbursement for pharmacies, and rein in abusive PBM practices that have contributed to rising drug costs and the closure of community pharmacies across the state.
AAM issues comments on Section 232 investigation on pharmaceuticals
“AAM and the generics and biosimilars industry look forward to working with the Commerce Department and the White House to engage constructively on ways to incent more domestic investment in the medicines supply chain,” said John Murphy III, president and CEO.
CVS Health Foundation and AACP continue program to reduce barriers for student pharmacists
Scholarships will help reduce financial barriers for student pharmacists.
AAM commends Senate Q1/Q2 bill introduction
Saves more than $800 million over 10 years; brings lower-cost medicines to patients soone
Brian Lawson appointed executive director of the Board of Pharmacy Specialties
Lawson succeeds William Ellis, who retired after 12 years of exemplary leadership as Executive Director of BPS.
Trump planned pharmaceutical tariffs could raise possibility of price hikes, shortages
It’s uncertain whether tariffs will influence more companies to make more drugs in the U.S. like Trump is hoping for, some experts said.
CHPA lauds lawmakers for urging FDA to safeguard Rx-OTC pathway
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
Camber launches Lurasidone Hydrochloride Tablets
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of Schizophrenia in adults and adolescents (13 to 17 years) and other depressive episodes.
Amneal donates $1.5 million to support patients during Parkinson’s Awareness Month
Amneal’s donations will be directed toward programs that offer funding support for out-of-pocket costs—including copayments, coinsurance, and deductibles—for FDA-approved Parkinson’s medications.
Dr. Debbie Kelly named 2025 Canadian Pharmacist of the Year
Dr. Kelly’s career began during the height of the HIV epidemic in the 1990s, where her early work in medication management helped improve treatment regimens and reduce side effects.
PCSC expands GDP Program with addition of four accredited companies
The Good Distribution Practices Accreditation Program aims to support pharmaceutical supply chain stakeholders, especially vendor service providers, in demonstrating compliance with globally recognized GDP operational and training standards.
Dexcom G7 15 Day receives FDA clearance
Dexcom G7 15 Day is now cleared in the U.S. for people age 18 years and above with diabetes.
Camber launches mycophenolate mofetil capsules
Mycophenolate mofetil capsules, USP 250 mg are available in 100 and 500 count bottles.
NCPA urges SCOTUS to reject radical change to legal procedure that could limit class action cases
Cases against PBMs and Big Insurers could be bogged by procedural hurdles if SCOTUS sides with petitioner, NCPA says.